rs1455865276
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_000517.6(HBA2):c.*98T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,508,844 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 25)
Exomes 𝑓: 0.000018 ( 1 hom. )
Consequence
HBA2
NM_000517.6 3_prime_UTR
NM_000517.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.162
Publications
0 publications found
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA2 Gene-Disease associations (from GenCC):
- alpha thalassemia spectrumInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- erythrocytosis, familial, 7Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hemoglobin M diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hb Bart's hydrops fetalisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin H diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Heinz body anemiaInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- methemoglobinemia, alpha typeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-173698-T-C is Benign according to our data. Variant chr16-173698-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 439111.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HBA2 | NM_000517.6 | c.*98T>C | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000251595.11 | NP_000508.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HBA2 | ENST00000251595.11 | c.*98T>C | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_000517.6 | ENSP00000251595.6 |
Frequencies
GnomAD3 genomes AF: 0.0000201 AC: 3AN: 149168Hom.: 0 Cov.: 25 show subpopulations
GnomAD3 genomes
AF:
AC:
3
AN:
149168
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000184 AC: 25AN: 1359676Hom.: 1 Cov.: 22 AF XY: 0.0000177 AC XY: 12AN XY: 677780 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
25
AN:
1359676
Hom.:
Cov.:
22
AF XY:
AC XY:
12
AN XY:
677780
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1
AN:
27264
American (AMR)
AF:
AC:
0
AN:
40250
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25012
East Asian (EAS)
AF:
AC:
8
AN:
37666
South Asian (SAS)
AF:
AC:
8
AN:
79888
European-Finnish (FIN)
AF:
AC:
0
AN:
50740
Middle Eastern (MID)
AF:
AC:
0
AN:
5454
European-Non Finnish (NFE)
AF:
AC:
7
AN:
1037128
Other (OTH)
AF:
AC:
1
AN:
56274
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.0000000000179143), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.384
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000201 AC: 3AN: 149168Hom.: 0 Cov.: 25 AF XY: 0.0000412 AC XY: 3AN XY: 72756 show subpopulations
GnomAD4 genome
AF:
AC:
3
AN:
149168
Hom.:
Cov.:
25
AF XY:
AC XY:
3
AN XY:
72756
show subpopulations
African (AFR)
AF:
AC:
1
AN:
38816
American (AMR)
AF:
AC:
0
AN:
15174
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3464
East Asian (EAS)
AF:
AC:
1
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4624
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
1
AN:
67998
Other (OTH)
AF:
AC:
0
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Nov 03, 2020
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Mar 27, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.